Lidocaine hydrochloride 0.04 MG/MG / menthol 0.05 MG/MG Medicated Patch — RxCUI 2600301
RxNorm drug concept · Semantic clinical drug
RxCUI 2600301
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2600301
Official nameLidocaine hydrochloride 0.04 MG/MG / menthol 0.05 MG/MG Medicated Patch
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine HCl 4 % / menthol 5 % Medicated Patch
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)116 prescriptions · 1 state & territory Medicaid programs · latest period Q1 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How Lidocaine hydrochloride 0.04 MG/MG / menthol 0.0... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine hydrochloride 0.04 MG/MG / menthol 0.05 MG/MG Medicated Patch
RxCUI 2600301 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Menthol
6750IN -
Lidocaine / menthol
1008818MIN -
Lidocaine hydrochloride
142440PIN
-
Lidocaine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine / menthol Medicated Patch
1792851SCDF -
Lidocaine hydrochloride / menthol Medicated Patch
2646205SCDFP -
Lidocaine / menthol Topical Product
1164045SCDG -
Lidocaine hydrochloride / menthol Topical Product
2661545SCDGP -
Medicated Patch
1792831DF -
Topical Product
1151122DFG
-
Lidocaine / menthol Medicated Patch
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine hydrochloride 0.04 MG/MG
1010076SCDC -
Menthol 0.05 MG/MG
336913SCDC
-
Lidocaine hydrochloride 0.04 MG/MG
Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine hydrochloride 0.04 MG/MG
SCDC · 1010076 -
Menthol 0.05 MG/MG
SCDC · 336913 -
Lidocaine / menthol Medicated Patch
SCDF · 1792851 -
Lidocaine hydrochloride / menthol Medicated Patch
SCDFP · 2646205 -
Lidocaine / menthol Topical Product
SCDG · 1164045 -
Lidocaine hydrochloride / menthol Topical Product
SCDGP · 2661545
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2600301 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70512-0015-15 | 3 POUCH in 1 BOX (70512-015-15) / 5 g in 1 POUCH | SynoFlex Patch | Sola Pharmaceuticals | 2022-04-28 |
Observed labelers:
Sola Pharmaceuticals (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.